These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6139453

  • 1. Elimination from the circulation of cats of 6-keto-prostaglandin E1 compared with prostaglandins E2 and I2.
    Förstermann U, Neufang B.
    J Pharm Pharmacol; 1983 Nov; 35(11):724-8. PubMed ID: 6139453
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK, Herzer WA, Zimmerman JB, Branch RA, Oates JA, Gerkens JF.
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of prostacyclin on the fetal pulmonary circulation.
    Cassin S, Winikor I, Tod M, Philips J, Frisinger J, Jordan J, Gibbs C.
    Pediatr Pharmacol (New York); 1981 Jan; 1(3):197-207. PubMed ID: 7050867
    [Abstract] [Full Text] [Related]

  • 11. Effects of the prostacyclin products, 6-keto prostaglandin E1 and 6-keto prostaglandin F1 alpha, on bone resorption in vitro.
    Neuman SD, Raisz LG.
    Prostaglandins Leukot Med; 1984 Jul; 15(1):103-8. PubMed ID: 6382342
    [Abstract] [Full Text] [Related]

  • 12. 6-Keto-prostaglandin E1-stimulated bone resorption in organ culture.
    Dewhirst FE.
    Calcif Tissue Int; 1984 Jul; 36(4):380-3. PubMed ID: 6435837
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL, Kadowitz PJ.
    J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
    Schwertschlag U, Stahl T, Hackenthal E.
    Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776
    [Abstract] [Full Text] [Related]

  • 18. Selective antagonism of the systemic vasodepressor response to PGE1 by d,1-11, 15-bisdeoxy PGE1.
    Stinger RB, Fitzpatrick TM, Van Dam J, Ramwell PW, Kot PA.
    Prostaglandins; 1980 Feb; 19(2):213-20. PubMed ID: 6992223
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I, Morise T, Yasuhara S, Takeda Y, Koshida H, Takeda R.
    Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.